Martin Busch

Title: Martin Busch: Innovator in Apoptotic Product Determination

Introduction

Martin Busch is a notable inventor based in Emmering, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the determination of apoptotic products in tumor patients undergoing therapy. With a total of 2 patents, his work has the potential to enhance the effectiveness of cancer treatments.

Latest Patents

Busch's latest patents focus on innovative methods for determining apoptotic products in patients. One of his inventions involves a method for assessing the concentration of apoptotic products in samples taken from patients, which correlates with the effectiveness of their therapy. This method is particularly useful for evaluating the effectiveness of tumor therapy by measuring nucleosome concentrations in serum samples. Additionally, his inventions also address the determination of therapy effectiveness in patients undergoing radiotherapy or chemotherapy, as well as those recovering from acute ischemic events or hypothermia treatment.

Career Highlights

Martin Busch is currently associated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His work at Roche has allowed him to focus on developing methods that can significantly improve patient outcomes in cancer therapy.

Collaborations

Busch has collaborated with notable colleagues such as Stefan Holdenrieder and Andreas Schalhorn, contributing to advancements in the field of medical diagnostics.

Conclusion

Martin Busch's innovative work in the determination of apoptotic products represents a significant advancement in cancer therapy monitoring. His contributions have the potential to improve treatment effectiveness and patient care in oncology.